Healthcare Policy Reforms

HS-PROD - Aiding Healthcare Policy Reforms
Ashok Kumar, Dy. Director General, Cental Bureau of Health Intelligence, Ministry of Health and Family Welfare, Government of India, India

Health Sector Policy Reform Option Database (HS-PROD) is a database for health sector reforms created by the Government of India. Its aim is to share reform know-how to tackle common management problems in the health sector.

Patient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative Research

Adherence to the long course of TB treatment is a complex, dynamic phenomenon with a wide range of factors impacting on treatment-taking behaviour. Patients' adherence to their medication regimens was influenced by the interaction of a number of these factors.

RG Stone Urological Research Institute, India
RG Stone Urological Research Institute (RG) has entered into a joint venture with ICICI Venture and announced that it plans to establish twenty new hospitals investing US$ 10 million.

KIMS, Hyderabad plans US$ 22 million expansion
The Hyderabad-based multi-speciality hospital, Krishna Institute of Medical Sciences (KIMS) plans to construct a 4 storey, ultra-modern medical centre.

HydroCision’s new Oval tip SpineJet XL(R) Fusion instruments
HydroCision Inc. 's SpineJet XL oval tip fluidjet instrument's are designed to enter the tight disc spaces and provides a solution to the disc preparation challenges inherent in spinal fusion procedures.

New needle-free jet injection to improve skin cancer treatment
Researchers at Queen's University in Belfast, Ireland have demonstrated a needle-free jet injection that increases the amount of cancer treatment agent when treating skin cancer.

Digital Imaging: The Continued Growth Of The PACS Market, 2006- 2011
While older PACS implementations do not include Radiology Information Systems (RISs) the two systems are continuously becoming more integrated. The central motivation for PACS is that it provides an improved level of care for patients. Within healthcare, solutions that provide clinical benefits are paramount and this is vital to ensuring the PACS market remains strong.